BTG3 and autoimmune hepatitis: The prevalence of ANA, SMA and anti-SLA/LP in AIH patients was examined in different geographical regions, including China, Japan, Iraq, Germany, France, Italy, Turkey, the United Kingdom, Austria and Sweden.